Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2021 08:30 ET | Source: ChemoCentryx, Inc.

Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP)

SAN CARLOS, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use...
November 12, 2021 07:30 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Reports Third Quarter 2021 Financial Results

Contract Manufacturer identified in prior CRL receives satisfactory resolution (VAI) of the facility’s identified deficiencies from the FDA Verrica is engaging with the FDA...
November 12, 2021 07:00 ET | Source: Xilio Therapeutics, Inc.

Xilio Therapeutics Announces Preclinical Data Demonstrating Anti-Tumor Activity and Tolerability of XTX301, a Tumor-Selective IL-12, at Society for Immunotherapy in Cancer Annual Meeting

WALTHAM, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq:XLO), a biotechnology company developing tumor-selective immuno-oncology therapies for patients with cancer, today...
November 12, 2021 07:00 ET | Source: Beam Therapeutics

Beam Therapeutics Reports Preclinical Data Highlighting Multiplex Base Editing Approach to Create Anti-CD5 CAR T-cell Investigational Therapies for T-Cell Malignancies

CAMBRIDGE, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced new...
November 12, 2021 07:00 ET | Source: Achilles Therapeutics PLC

Achilles Therapeutics Presents Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Demonstrating the Ability to Detect, Quantify and Track Patient-specific cNeT and Significant Increase in cNeT Dose from VELOS™ Process 2 Manufacturing

LONDON, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today...
November 12, 2021 04:49 ET | Source: Fortune Business Insights

Worldwide Video Streaming Market Industry is Expected to Reach USD 842.93 Billion by 2027 at a CAGR of 12.0% from 2021

Pune, India, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The global video streaming market share, size is likely to hit USD 842.93 billion by 2027, exhibiting a CAGR of 12.0% during the forecast timescale....
November 12, 2021 04:13 ET | Source: Research and Markets

Worldwide Optical Coherence Tomography Industry to 2029 - Players Include Carl Zeiss Meditec, Optovue and Thorlabs Among Others

Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "Optical Coherence Tomography Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
November 11, 2021 18:05 ET | Source: Dundee Precious Metals, Inc.

Dundee Precious Metals Announces 2021 Third Quarter Results; Delivers Another Quarter of Strong Free Cash Flow

(All monetary figures are expressed in U.S. dollars unless otherwise stated) TORONTO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or the “Company”) today...
November 11, 2021 16:05 ET | Source: Beyond Air™

Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022

U.S. FDA actively reviewing premarket approval (PMA) submission for LungFit® PH to treat persistent pulmonary hypertension of the newborn (PPHN); Remain on track for commercial launch in the fourth...
November 11, 2021 16:05 ET | Source: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Announces Third Quarter 2021 Results and Provides Corporate Update

Clinical Drug Pipeline is Funded and Targeting Major Milestones mid-2022 HANOVER, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the...